Missing/wrong data?
Log in to edit
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).
scientific article published on 4 March 2017
Author/s
author: Howard Trachtman, Vimal K. Derebail, Debbie S Gipson
Work details
Publication date
March 4, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.